Investigating a new generation of ribozymes in order to target HCV.

For a long time nucleic acid-based approaches directed towards controlling the propagation of Hepatitis C Virus (HCV) have been considered to possess high potential. Towards this end, ribozymes (i.e. RNA enzymes) that specifically recognize and subsequently catalyze the cleavage of their RNA substra...

Full description

Saved in:
Bibliographic Details
Main Authors: Michel V Lévesque, Dominique Lévesque, Francis P Brière, Jean-Pierre Perreault
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-03-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0009627&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850133978649985024
author Michel V Lévesque
Dominique Lévesque
Francis P Brière
Jean-Pierre Perreault
author_facet Michel V Lévesque
Dominique Lévesque
Francis P Brière
Jean-Pierre Perreault
author_sort Michel V Lévesque
collection DOAJ
description For a long time nucleic acid-based approaches directed towards controlling the propagation of Hepatitis C Virus (HCV) have been considered to possess high potential. Towards this end, ribozymes (i.e. RNA enzymes) that specifically recognize and subsequently catalyze the cleavage of their RNA substrate present an attractive molecular tool. Here, the unique properties of a new generation of ribozymes are taken advantage of in order to develop an efficient and durable ribozyme-based technology with which to target HCV (+) RNA strands. These ribozymes resulted from the coupling of a specific on/off adaptor (SOFA) to the ribozyme domain derived from the Hepatitis Delta Virus (HDV). The former switches cleavage activity "on" solely in the presence of the desired RNA substrate, while the latter was the first catalytic RNA reported to function naturally in human cells, specifically in hepatocytes. In order to maximize the chances for success, a step-by-step approach was used for both the design and the selection of the ribozymes. This approach included the use of both bioinformatics and biochemical methods for the identification of the sites possessing the greatest potential for targeting, and the subsequent in vitro testing of the cleavage activities of the corresponding SOFA-HDV ribozymes. These efforts led to a significant improvement in the ribozymes' designs. The ability of the resulting SOFA-HDV ribozymes to inhibit HCV replication was further examined using a luciferase-based replicon. Although some of the ribozymes exhibited high levels of cleavage activity in vitro, none appears to be a potential long term inhibitor in cellulo. Analysis of recent discoveries in the cellular biology of HCV might explain this failure, as well as provide some ideas on the potential limits of using nucleic acid-based drugs to control the propagation of HCV. Finally, the above conclusions received support from experiments performed using a collection of SOFA-HDV ribozymes directed against HCV (-) strands.
format Article
id doaj-art-32defbadfebf44d29c990ac83b852d8e
institution OA Journals
issn 1932-6203
language English
publishDate 2010-03-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-32defbadfebf44d29c990ac83b852d8e2025-08-20T02:31:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-03-0153e962710.1371/journal.pone.0009627Investigating a new generation of ribozymes in order to target HCV.Michel V LévesqueDominique LévesqueFrancis P BrièreJean-Pierre PerreaultFor a long time nucleic acid-based approaches directed towards controlling the propagation of Hepatitis C Virus (HCV) have been considered to possess high potential. Towards this end, ribozymes (i.e. RNA enzymes) that specifically recognize and subsequently catalyze the cleavage of their RNA substrate present an attractive molecular tool. Here, the unique properties of a new generation of ribozymes are taken advantage of in order to develop an efficient and durable ribozyme-based technology with which to target HCV (+) RNA strands. These ribozymes resulted from the coupling of a specific on/off adaptor (SOFA) to the ribozyme domain derived from the Hepatitis Delta Virus (HDV). The former switches cleavage activity "on" solely in the presence of the desired RNA substrate, while the latter was the first catalytic RNA reported to function naturally in human cells, specifically in hepatocytes. In order to maximize the chances for success, a step-by-step approach was used for both the design and the selection of the ribozymes. This approach included the use of both bioinformatics and biochemical methods for the identification of the sites possessing the greatest potential for targeting, and the subsequent in vitro testing of the cleavage activities of the corresponding SOFA-HDV ribozymes. These efforts led to a significant improvement in the ribozymes' designs. The ability of the resulting SOFA-HDV ribozymes to inhibit HCV replication was further examined using a luciferase-based replicon. Although some of the ribozymes exhibited high levels of cleavage activity in vitro, none appears to be a potential long term inhibitor in cellulo. Analysis of recent discoveries in the cellular biology of HCV might explain this failure, as well as provide some ideas on the potential limits of using nucleic acid-based drugs to control the propagation of HCV. Finally, the above conclusions received support from experiments performed using a collection of SOFA-HDV ribozymes directed against HCV (-) strands.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0009627&type=printable
spellingShingle Michel V Lévesque
Dominique Lévesque
Francis P Brière
Jean-Pierre Perreault
Investigating a new generation of ribozymes in order to target HCV.
PLoS ONE
title Investigating a new generation of ribozymes in order to target HCV.
title_full Investigating a new generation of ribozymes in order to target HCV.
title_fullStr Investigating a new generation of ribozymes in order to target HCV.
title_full_unstemmed Investigating a new generation of ribozymes in order to target HCV.
title_short Investigating a new generation of ribozymes in order to target HCV.
title_sort investigating a new generation of ribozymes in order to target hcv
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0009627&type=printable
work_keys_str_mv AT michelvlevesque investigatinganewgenerationofribozymesinordertotargethcv
AT dominiquelevesque investigatinganewgenerationofribozymesinordertotargethcv
AT francispbriere investigatinganewgenerationofribozymesinordertotargethcv
AT jeanpierreperreault investigatinganewgenerationofribozymesinordertotargethcv